Fortune

EDITOR-IN-CHIEF Alyson Shontell EXECUTIVE EDITOR, FEATURES Matthew Heimer MANAGING EDITOR Holly Epstein Ojalvo EXECUTIVE EDITOR, NEWS Nick Lichtenberg EXECUTIVE EDITOR, SUCCESS Lindsey Stanberry EXECUTIVE EDITOR, ASIA Clay Chandler (Hong Kong) EDITOR

FOR BUSINESS, 2022 has been a dizzying year, and the fourth quarter has only upped the ante on the insanity. In November alone, we watched Elon Musk take over Twitter and decimate the company and its workforce, one tweet at a time. A $32 billion cryp

STARTUPS SEEKING to go public faced a tough time in 2022, as a sobering economic reality extinguished the overblown valuations and rapid dealmaking that defined Silicon Valley in recent years. As of mid-November, there had been only 64 IPOs with a ma

To quote a colleague: Oof. We believed our “Stocks for Smoother Sailing” for 2022 would withstand inflation. But prices and interest rates rose far faster than we expected, and our picks lost a median of 41% over the past 12 months. Here’s how it wen

WHAT MIGHT BE the next industry to get Amazon’s AWS-style mega-venture treatment? The leading candidate is health care. In 2018 Amazon bought PillPack, an online pharmacy, and last summer it paid $3.9 billion for One Medical, a membership-based prima

Ophthalmologist Private Practice New York, NY Recognized for more than four decades of contributions to the field of ophthalmology, Dr. Barry Miles Belgorod has earned distinction for his work in private practice. In this capacity, he has demonstrate